ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $206,828 | -96.8% | 5,800 | -95.9% | 0.00% | -96.9% |
| Q1 2022 | $6,563,000 | -69.1% | 142,700 | -55.5% | 0.03% | -69.8% |
| Q4 2021 | $21,257,000 | -57.3% | 320,617 | -59.8% | 0.11% | -54.3% |
| Q3 2021 | $49,730,000 | +64.5% | 796,578 | +118.2% | 0.23% | +88.6% |
| Q2 2021 | $30,229,000 | +164.4% | 365,000 | +111.7% | 0.12% | +115.8% |
| Q1 2021 | $11,435,000 | +120.5% | 172,454 | +155.1% | 0.06% | +83.9% |
| Q4 2020 | $5,187,000 | -71.6% | 67,600 | -84.0% | 0.03% | -75.4% |
| Q3 2020 | $18,240,000 | -47.2% | 423,600 | -47.0% | 0.13% | -54.5% |
| Q2 2020 | $34,552,000 | +20.1% | 800,000 | -20.0% | 0.28% | +12.1% |
| Q1 2020 | $28,770,000 | +353.6% | 1,000,000 | +900.0% | 0.25% | +474.4% |
| Q4 2019 | $6,343,000 | -65.4% | 100,000 | -84.6% | 0.04% | -68.8% |
| Q3 2019 | $18,317,000 | -65.4% | 650,000 | -67.5% | 0.14% | -60.0% |
| Q2 2019 | $53,000,000 | +50.4% | 2,000,000 | +4.1% | 0.34% | +30.2% |
| Q1 2019 | $35,243,000 | +89.2% | 1,920,609 | +28.0% | 0.26% | +93.4% |
| Q4 2018 | $18,630,000 | – | 1,500,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |